Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 10,000 shares at $13.20 ($132K) on 2019-07-01, disclosed to the SEC on 2019-07-02.
Open-market sale of $132k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.20 | 7,805 | $103K | 78.1% |
| 2 | $13.16 | 2,195 | $29K | 21.9% |
| Total | $13.19 avg | 10,000 | $132K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |